Synthesis and anti-inflammatory activity of chalcone derivatives

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 10, 1998, Pages 1169-1174

  Herencia, Felipe ^a   Ferrándiz, M Luisa ^a   Ubeda, Amalia ^a   Domínguez, José N ^b   Charris, Jaime E ^b   Lobo, Gricela M ^b   Alcaraz, M José ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CHALCONE DERIVATIVE;

ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; DEGRANULATION; DRUG SYNTHESIS; ENZYME ACTIVITY; INFLAMMATION; MOUSE; NONHUMAN;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONATE 5-LIPOXYGENASE; CHALCONE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DRUG DESIGN; HUMANS; ISOENZYMES; LEUKOTRIENE B4; LIPOXYGENASE INHIBITORS; MEMBRANE PROTEINS; MICE; MOLECULAR STRUCTURE; NEUTROPHILS; PROPIOPHENONES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA;

EID: 0032546508     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00179-6     Document Type: Article

References (15)

1. 1. Hla, T.; Neilson, K. Proc. Natl. Acad. Sci. U. S. A. 1992, 89, 7384.
2. 2. Masferrer, J. L.; Zweifel, B. S.; Manning, P. T.; Hauser, S. D.; Leahy, K. M.; Smith, W. G.; Isakson, P. C.; Seibert, K. Proc. Natl. Acad. Sci. USA 1994, 91, 3228.
3. 3. Lewis, R. A.; Austen, K. F.; Soberman, R. J. New England J. Med. 1990, 323, 645.
4. 4. Henderson, W. R. Ann. Intern. Med. 1994, 121, 684.
5. 5. Bjorkman, D. J. Am. J. Med. 1996, 101 (suppl 1A), 25S.
6. 6. Ballesteros, J. F.; Sanz, M. J.; Ubeda, A.; Miranda, M. A.; Iborra, S.; Payá, M.; Alcaraz, M. J. J. Med. Chem. 1995, 38, 2794.
7. 7. Li, R., Kenyon, G.L., Cohen, F.E., Chem., X., Gong, B., Dominguez, J.N., Davidson, E., Kurzban, G., Miller, R.E., Rosenthal, P.J. and McKerrow, J.H. J.Med.Chem. 1995, 38, 5031.
8. 3), 7.12 (s, 1H, 5′-H), 7.26 (d, J=11 Hz, 1H, 5-H), 7.61 (dd, J=7.8 and 1.2 Hz, 1H, 6-H), 7.78 (dd, J=1.2 and 7.8 Hz, 1H, 7-H), 7.89 (d, J=8.2 Hz, 1H, 8-H), 8.02 (d, J=9 Hz, 1H, α -H), 8.06 (d, J=12 Hz, 1H, β-H), 8.4 (s, 1H, 4-H). In addition all compounds had IR, LSIMS and elemental analysis in complete agreement with the assigned structures.
9. 3) 6.51 (m, 1H, 5′-H), 6.75 (d, J=3.21 Hz, 1H, 3-H), 7.36 (d, J=15.7 Hz, 1H, α-H), 7.55 (m, 2H, 4 and 5-H), 7.59 (d, J=15.7 Hz, 1H, β-H), 7.83 (dd, J-8.09 and 1.72 Hz, 1H, 6′-H), 8.08 (d, J=1.75 Hz, 1H, 2′-H). In addition all compounds had IR, LSIMS and elemental analysis in complete agreement with the assigned structures.
10. 10. Meth-Cohn, O., Narine, B. and Tarnowski, B. J. Chem.Soc. Perkin I., 1981, 1520.
11. 11. Escrig, V.; Ubeda, A.; Ferrándiz, M. L.; Darias, J.; Sánchez, J. M.; Alcaraz, M. J.; Payá, M. J. Pharmacol. Exp. Ther. 1997, 282, 123.
12. 12. Franson, R.; Patriarca, P.; Elsbach, P. J. Lipid Res. 1974, 15, 380.
13. 13. Payá, M.; Terencio, M. C.; Ferrándiz, M. L.; Alcaraz, M. J. Br. J. Pharmacol. 1996, 117, 1773.
14. 14. Betts, W. H. Detecting oxy radicals by chemiluminescence. In: Handbook of methods for oxygen radical research; Greenwald, R. A. Ed. CRC Press: Boca Raton, 1985; pp 197-201.
15. 15. Jeong, J.-Y.; Jue, D.-M. J. Immunol. 1997, 158, 4901.